Cancer Diagnosis and Treatment
Tuesday, 20 October 2026
Contributions
Richard Baker (Glenrothes and Mid Fife) (Lab)Labour
11. What steps she is taking to improve cancer diagnosis and treatment.
The Secretary of State for Health and Social Care (Yvette Cooper)Labour
The national cancer plan sets out how the Government will continue to reduce waiting times for diagnosis and treatment, and use new research technology and clinical trials to transform outcomes. Alongside the Prime Minister, last week I met Archie Goodburn in Downing Street to discuss the new action that we are taking on brain cancer, and our determination to tackle every form of that cruel disease.
That action will be welcomed across the House. Each year, about 20,000 men in Scotland are diagnosed with prostate cancer, and between half and two-thirds of them could benefit from focal therapy, which has a fivefold lower risk of harmful side effects compared with conventional treatments. Will my right hon. Friend share learning and data from the expansion of focal therapy provision in England with Scottish Ministers, as it is still not available in Scotland, despite NHS Fife being well placed to provide a national centre for focal therapy treatment in Scotland?
My hon. Friend makes an important point about the importance of improving prostate cancer treatment, which affects so many men across the UK. We are investing £2.8 million to expand access to focal therapy in specialist centres in England, and NICE will look at the progress that is being made. We would of course be keen to work with the Scottish Government on this, and for them to be able to see the same results. It is important that we continue to improve treatment.
Carla Lockhart (Upper Bann) (DUP)Democratic Unionist Party
Scott, aged 30, is a dad, a son, a partner and a much-loved member of the Banbridge community, but he is battling grade 4 brain cancer. Brain cancer is the biggest killer of young people under the age of 40 in the UK, and survival rates are lower than the average across all cancers. Access to clinical trials is negligible, with only 2% of brain tumour patients successfully accessing them. Will the Secretary of State expand brain tumour clinical trials across the United Kingdom, and ensure fair access across all nations?
I pay tribute to the hon. Lady’s constituent, who is obviously undergoing the most difficult of circumstances, and it is exactly because this is such a devastating condition that we have introduced a three-month rapid review of all the research and barriers to getting more patients into trials. We are of course keen to continue to work with the devolved Governments on this, because the research benefits us all right across the United Kingdom. We will be drawing up a framework to get drugs more quickly into trials, and to get more patients into those trials.
Source: UK Parliament Hansard API. Debate ID: 5420666.